Dr. Linda Rhodes
life sciences
Zoetis
United States of America
Biography
Dr. Linda Rhodes has served as a member of our board since August 2017. Dr. Rhodes most recently served as the Chief Scientific Officer of Aratana Therapeutics, a publicly traded animal health company, from 2012 to 2016, and she had also served as Chief Executive Officer of Aratana from 2011 to 2012. Dr. Rhodes has extensive experience as a research scientist, academic, veterinary practitioner and business leader, spanning nearly 30 years across the animal health industry. She is a founder of AlcheraBio, LLC, a veterinary contract research organization, and held research positions with Merial, Merck and Company, and Sterling-Winthrop Drug Company. She also held several teaching positions and worked as a bovine veterinarian in private practice for many years. Dr. Rhodes formerly served as a member of the Board of Directors of ImmuCell Corporation. She is currently an adjunct professor for the Graduate School of Animal Science at Rutgers University.
Research Interest
Dr. Linda Rhodes has served as a member of our board since August 2017. Dr. Rhodes most recently served as the Chief Scientific Officer of Aratana Therapeutics, a publicly traded animal health company, from 2012 to 2016, and she had also served as Chief Executive Officer of Aratana from 2011 to 2012. Dr. Rhodes has extensive experience as a research scientist, academic, veterinary practitioner and business leader, spanning nearly 30 years across the animal health industry. She is a founder of AlcheraBio, LLC, a veterinary contract research organization, and held research positions with Merial, Merck and Company, and Sterling-Winthrop Drug Company. She also held several teaching positions and worked as a bovine veterinarian in private practice for many years. Dr. Rhodes formerly served as a member of the Board of Directors of ImmuCell Corporation. She is currently an adjunct professor for the Graduate School of Animal Science at Rutgers University.
